Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV955
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,515
Award facts
- Contract value 100% obligated
- $32,514.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,514.90 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on January 30, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 2, 2026, and performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. The IDC enables the company to deliver a broad range of pharmaceutical products, medical supplies, specialty medications, and vaccines to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government medical institutions. Dupixent is a biologic treatment commonly prescribed for eczema, asthma, and other inflammatory conditions, making this order consistent with the company's role as a critical vendor for federal medical procurement across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FV955?
SPE2DR26FV955 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FV955 worth?
The government has obligated $32,515 on SPE2DR26FV955.
Is contract SPE2DR26FV955 an order under another contract?
Yes. SPE2DR26FV955 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV955 competed?
The extent of competition for SPE2DR26FV955 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award